Hypertension Clinical Trials in Taipei
11 recruitingTaipei, Taiwan
Showing 1–11 of 11 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Pulmonary Hypertension Associated With HFpEF
Tenax Therapeutics, Inc.540 enrolled92 locationsNCT07288398
Recruiting
Not Applicable
Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
Diabetes MellitusCardiovascular DiseasesHypertension+2 more
Medtronic Vascular130 enrolled19 locationsNCT07115953
Recruiting
Phase 3
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
Hypertension, Pulmonary
Actelion280 enrolled43 locationsNCT05179876
Recruiting
Phase 2
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
AstraZeneca218 enrolled70 locationsNCT07222917
Recruiting
Not Applicable
A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary Hypertension
Artificial Intelligence (AI)Hypertension, PulmonaryArtificial Intelligence (AI) in Diagnosis
National Defense Medical Center, Taiwan8,666 enrolled1 locationNCT07079592
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
iCaReMe Global Registry
Heart FailureHypertensionChronic Kidney Disease+1 more
AstraZeneca35,000 enrolled55 locationsNCT03549754
Recruiting
Phase 2
Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD
Group 3 Pulmonary Hypertension
Foresee Pharmaceuticals Co., Ltd.126 enrolled9 locationsNCT06475781
Recruiting
Phase 4
INtraprocedural Feedback-Optimized Renal Denervation Based on Measurements Obtained Through Renal Artery Stimulation: a Randomized Controlled Trial (INFORM)
HypertensionHypertension, UncontrolledHypertension, Resistant
National Taiwan University Hospital32 enrolled1 locationNCT06676553
Recruiting
Phase 4
Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation
Hypertension
National Taiwan University Hospital60 enrolled1 locationNCT05421767